{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:25:23Z","timestamp":1762928723254,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:00:00Z","timestamp":1570233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T00:00:00Z","timestamp":1570233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s00403-019-01988-9","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T13:02:23Z","timestamp":1570280543000},"page":"289-294","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of the pathogenicity of anti-desmoglein antibodies of pemphigus vulgaris patients using human organ culture assay"],"prefix":"10.1007","volume":"312","author":[{"given":"Ayat M.","family":"Saleh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solwan I.","family":"El-Samanoudy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laila A.","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9487-8708","authenticated-orcid":false,"given":"Marwah Adly","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,5]]},"reference":[{"issue":"2 Pt 1","key":"1988_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","volume":"40","author":"M Amagai","year":"1999","unstructured":"Amagai M, Tsunoda K, Zillikens D, Nagai T, Nishikawa T (1999) The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 40(2 Pt 1):167\u2013170","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"1988_CR2","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1038\/sj.jid.5700457","volume":"126","author":"M Amagai","year":"2006","unstructured":"Amagai M (2006) Non-pathogenic anti-desmoglein 3 IgG autoantibodies in Fogo Selvagem. J Invest Dermatol 126(9):1931\u20131932","journal-title":"J Invest Dermatol"},{"key":"1988_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1146\/annurev-pathol-012615-044313","volume":"11","author":"CM Hammers","year":"2016","unstructured":"Hammers CM, Stanley JR (2016) Mechanisms of disease: pemphigus and bullous pemphigoid. Annu Rev Pathol 11:175\u2013197","journal-title":"Annu Rev Pathol"},{"issue":"9","key":"1988_CR4","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1038\/sj.jid.5700388","volume":"126","author":"J Hilario-Vargas","year":"2006","unstructured":"Hilario-Vargas J, Dasher DA, Li N, Aoki V, Hans-Filho G, dos Santos V et al (2006) Prevalence of anti-desmoglein-3 antibodies in endemic regions of Fogo selvagem in Brazil. J Invest Dermatol 126(9):2044\u20132048","journal-title":"J Invest Dermatol"},{"issue":"5","key":"1988_CR5","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.0022-202X.2005.23714.x","volume":"124","author":"K Ishii","year":"2005","unstructured":"Ishii K, Harada R, Matsuo I, Shirakata Y, Hashimoto K, Amagai M (2005) In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 IgG autoantibodies in pemphigus vulgaris. J Invest Dermatol 124(5):939\u2013946","journal-title":"J Invest Dermatol"},{"issue":"11","key":"1988_CR6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/1346-8138.12278","volume":"40","author":"Y Ito","year":"2013","unstructured":"Ito Y, Kasai H, Yoshida T, Saleh MA, Amagai M, Yamagami J (2013) Anti-type VII collagen autoantibodies, detected by enzyme-linked immunosorbent assay, fluctuate in parallel with clinical severity in patients with epidermolysis bullosa acquisita. J Dermatol 40(11):864\u2013868","journal-title":"J Dermatol"},{"issue":"6","key":"1988_CR7","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1067\/mjd.2003.438","volume":"48","author":"MJ Jamora","year":"2003","unstructured":"Jamora MJ, Jiao D, Bystryn JC (2003) Antibodies to desmoglein 1 and 3, and the clinical phenotype of pemphigus vulgaris. J Am Acad Dermatol 48(6):976\u2013977","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"1988_CR8","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1365-2133.2012.10929.x","volume":"167","author":"K Kamiya","year":"2012","unstructured":"Kamiya K, Aoyama Y, Shirafuji Y, Hamada T, Morizane S, Fujii K et al (2012) Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance. Br J Dermatol 167(2):252\u2013261","journal-title":"Br J Dermatol"},{"issue":"9","key":"1988_CR9","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1468-3083.2008.02715.x","volume":"22","author":"EJ Kwon","year":"2008","unstructured":"Kwon EJ, Yamagami J, Nishikawa T, Amagai M (2008) Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission. J Eur Acad Dermatol Venereol 22(9):1070\u20131075","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1988_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1172\/JCI5252","volume":"103","author":"MG Mahoney","year":"1999","unstructured":"Mahoney MG, Wang Z, Rothenberger K, Koch PJ, Amagai M, Stanley JR (1999) Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 103(4):461\u2013468","journal-title":"J Clin Invest"},{"issue":"3","key":"1988_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2133.1977.tb06141.x","volume":"96","author":"B Michel","year":"1977","unstructured":"Michel B, Ko CS (1977) An organ culture model for the study of pemphigus acantholysis. Br J Dermatol 96(3):295\u2013302","journal-title":"Br J Dermatol"},{"issue":"4","key":"1988_CR12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1172\/JCI24185","volume":"115","author":"AS Payne","year":"2005","unstructured":"Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y et al (2005) Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest 115(4):888\u2013899","journal-title":"J Clin Invest"},{"issue":"10","key":"1988_CR13","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1038\/jid.2009.72","volume":"129","author":"M Rosenbach","year":"2009","unstructured":"Rosenbach M, Murrell DF, Bystryn JC, Dulay S, Dick S, Fakharzadeh S et al (2009) Reliability and convergent validity of two outcome instruments for pemphigus. J Invest Dermatol 129(10):2404\u20132410","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1988_CR14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jaad.2018.01.029","volume":"79","author":"MA Saleh","year":"2018","unstructured":"Saleh MA (2018) A prospective study comparing patients with early and late relapsing pemphigus treated with rituximab. J Am Acad Dermatol 79(1):97\u2013103","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1988_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/1346-8138.12676","volume":"42","author":"MA Saleh","year":"2015","unstructured":"Saleh MA (2015) Pemphigus in the Arab World. J Dermatol 42(1):27\u201330","journal-title":"J Dermatol"},{"issue":"10","key":"1988_CR16","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/ijd.12662","volume":"54","author":"MA Saleh","year":"2015","unstructured":"Saleh MA, El-Bahy MM (2015) Do normal Egyptians possess anti-desmoglein 3 antibodies? Int J Dermatol 54(10):1145\u20131149","journal-title":"Int J Dermatol"},{"issue":"4","key":"1988_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/jid.2011.449","volume":"132","author":"MA Saleh","year":"2012","unstructured":"Saleh MA, Ishii K, Yamagami J, Shirakata Y, Hashimoto K, Amagai M (2012) Pathogenic anti-desmoglein 3 mAbs cloned from a paraneoplastic pemphigus patient by phage display. J Invest Dermatol 132(4):1141\u20131148","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1988_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1172\/JCI109189","volume":"62","author":"JR Schiltz","year":"1978","unstructured":"Schiltz JR, Michel B, Papay R (1978) Pemphigus antibody interaction with human epidermal cells in culture. J Clin Invest 62(4):778\u2013788","journal-title":"J Clin Invest"},{"issue":"6","key":"1988_CR19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1684\/ejd.2015.2652","volume":"25","author":"A Sinistro","year":"2015","unstructured":"Sinistro A, Calabresi V, Lupi F, Sera F, Frezzolini A, Ruffelli M et al (2015) The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris. Eur J Dermatol 25(6):578\u2013585","journal-title":"Eur J Dermatol"},{"issue":"4","key":"1988_CR20","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.4049\/jimmunol.170.4.2170","volume":"170","author":"K Tsunoda","year":"2003","unstructured":"Tsunoda K, Ota T, Aoki M, Yamada T, Nagai T, Nakagawa T et al (2003) Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 170(4):2170\u20132178","journal-title":"J Immunol"},{"issue":"3","key":"1988_CR21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jdermsci.2016.12.010","volume":"85","author":"K Yoshida","year":"2017","unstructured":"Yoshida K, Ishii K, Shimizu A, Yokouchi M, Amagai M, Shiraishi K et al (2017) Non-pathogenic pemphigus foliaceus (PF) IgG acts synergistically with a directly pathogenic PF IgG to increase blistering by p38MAPK-dependent desmoglein 1 clustering. J Dermatol Sci 85(3):197\u2013207","journal-title":"J Dermatol Sci"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-01988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-019-01988-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-019-01988-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T23:31:26Z","timestamp":1601767886000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-019-01988-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,5]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1988"],"URL":"https:\/\/doi.org\/10.1007\/s00403-019-01988-9","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"type":"print","value":"0340-3696"},{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2019,10,5]]},"assertion":[{"value":"30 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The author declares that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}